Speciation in enterobacteria involved horizontal gene transfer. Therefore, analysis of genes acquired by horizontal transfer that are present in one species but not its close relatives is expected to give insights into how new bacterial species were formed. In this study we characterize iroN, a gene located downstream of theiroBC operon in the iroA locus ofSalmonella enterica serotype Typhi. Like iroBC, the iroN gene is present in all phylogenetic lineages ofS. enterica but is absent from closely related species such as Salmonella bongori or Escherichia coli. Comparison of the deduced amino acid sequence of iroN with other proteins suggested that this gene encodes an outer membrane siderophore receptor protein. Mutational analysis in S. enterica and expression in E. coli identified a 78-kDa outer membrane protein as the iroN gene product. When introduced into an E. coli fepA cir fiu aroB mutant on a cosmid, iroN mediated utilization of structurally related catecholate siderophores, includingN-(2,3-dihydroxybenzoyl)-l-serine, myxochelin A, benzaldehyde-2,3-dihydroxybenzhydrazone, 2-N,6-N-bis(2,3-dihydroxybenzoyl)-l-lysine, 2-N,6-N-bis(2,3-dihydroxybenzoyl)-l-lysine amide, and enterochelin. These results suggest that theiroA locus functions in iron acquisition in S. enterica.
SummaryThe lpf operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches. To investigate expression of this virulence factor, a transcriptional fusion between the lpf operon and the genes lacZYA of Escherichia coli was constructed and introduced into the S. typhimurium chromosome. The resulting strain yielded both Lac þ and Lac ¹ colony phenotypes. Alternation between Lac þ (phase ON) and Lac ¹ (phase OFF) phenotypes occurred by a heritable phase variation mechanism, as inoculation of broth cultures with bacteria picked from a Lac þ colony gave rise to a considerably higher proportion of Lac þ colonies than inoculation with bacteria picked from a Lac ¹ colony. During growth in vitro, phase transition from ON to OFF and from OFF to ON occurred at rates of 6.8 × 10 ¹3 and 2.4 × 10 ¹4 events per cell per generation respectively. In a murine intestinal organ culture model, selection for the ON expression state occurred when attached bacteria were recovered from Peyer's patches, suggesting that Lac phase variation correlated with expression of lpf mediated adherence. Selection for either the ON or the OFF expression state of the lpf operon in vivo was studied in mice immunized with either GST or GST-LpfA fusion protein. A strong selection against phase ON cells occurred only in animals immunized with GST-LpfA.
Conventional wisdom holds that phase variation is a mechanism for immune evasion. However, despite fimbrial phase variation, mice previously exposed to Salmonella typhimurium are protected against a subsequent challenge. We evaluated whether lpf phase variation instead may be a mechanism to evade cross-immunity between Salmonella serotypes. Mice were immunized orally with S. typhimurium aroA mutants either that expressed the lpf operon (phase-on variant) or in which the entire lpf operon had been removed by deletion. During a subsequent challenge with virulent Salmonella enteritidis a selection against lpf phase-on variants was observed in mice previously exposed to S. typhimurium long polar fimbriae. Vaccination with S. typhimurium did not confer protection against challenge with S. enteritidis, presumably because lpf phase-off variants were able to evade cross-immunity. We propose that lpf phase variation is a mechanism to evade cross-immunity between Salmonella serotypes, thereby allowing their coexistence in a host population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.